ATE337019T1
Charged lipids and uses for the same
Abstract
The present invention is directed to charged lipids, compositions comprising charged lipids, and the use of these compositions in drug delivery, targeted drug delivery, therapeutic imaging and diagnostic imaging, as well as their use as contrast agents.
Term
Term ended
Projected expiry passed 25 February 2018, 8.6 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
55 members in 9 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 82379197 | United States of America | A | |
| 85178097 | United States of America | A | |
| 87782697 | United States of America | A | |
| 88721597 | United States of America | A | |
| 92535397 | United States of America | A |
Members55
| Document | Office | Kind | |
|---|---|---|---|
| WO9842383A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9842384A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6185398A | Australia | A | |
| AU6679198A | Australia | A | |
| WO9850040A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9850041A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6971998A | Australia | A | |
| AU6974798A | Australia | A | |
| WO9857670A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US6028066A | United States of America | A | |
| EP0988061A1 | European Patent Office (EPO) | A1 | |
| EP1015039A1 | European Patent Office (EPO) | A1 | |
| US6090800A | United States of America | A | |
| US6120751A | United States of America | A | |
| AR012107A1 | Argentina | A1 | |
| EP1037673A1 | European Patent Office (EPO) | A1 | |
| US6143276A | United States of America | A | |
| AR012656A1 | Argentina | A1 | |
| JP2001514615A | Japan | A | |
| EP0988061A4 | European Patent Office (EPO) | A4 | |
| EP1037673A4 | European Patent Office (EPO) | A4 | |
| CA2428606A1 | Canada | A1 | |
| WO0236161A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1328502A | Australia | A | |
| US6403056B1 | United States of America | B1 | |
| US6444660B1 | United States of America | B1 | |
| EP1015039A4 | European Patent Office (EPO) | A4 | |
| US2002159951A1 | United States of America | A1 | |
| US2003054027A1 | United States of America | A1 | |
| US6537246B1 | United States of America | B1 | |
| US2003120204A1 | United States of America | A1 | |
| CA2473748A1 | Canada | A1 | |
| WO03061593A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0236161A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1365805A2 | European Patent Office (EPO) | A2 | |
| WO03061593A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US6808720B2 | United States of America | B2 | |
| EP1478276A2 | European Patent Office (EPO) | A2 | |
| JP2005500245A | Japan | A | |
| US2005019266A1 | United States of America | A1 | |
| JP2005516033A | Japan | A | |
| EP1478276A4 | European Patent Office (EPO) | A4 | |
| EP1037673B1 | European Patent Office (EPO) | B1 | |
| US7105151B2 | United States of America | B2 | |
| AT337019T | Austria | T | |
| ATE337019T1This record | Austria | T1 | |
| DE69835692D1 | Germany | D1 | |
| AU2002213285B2 | Australia | B2 | |
| US2007059248A1 | United States of America | A1 | |
| AU2003210631B2 | Australia | B2 | |
| EP1015039B1 | European Patent Office (EPO) | B1 | |
| AT406179T | Austria | T | |
| ATE406179T1 | Austria | T1 | |
| DE69839940D1 | Germany | D1 | |
| US7452551B1 | United States of America | B1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 98906695
Titles2
- German
- GELADENE LIPIDE UND DEREN VERWENDUNG
- English
- CHARGED LIPIDS AND THEIR USE
Classification
- CPC, 5
- A61K49/223
- A61K9/1271
- A61K41/0028
- A61K47/544
- Y10T428/2984
- IPC, 3
- A61K9 127
- A61K41 00
- A61K49 22